Hemiacetal-less rapamycin derivatives designed and produced by genetic engineering of a type I polyketide synthase.

Kudo K, Nishimura T, Kozone I, Hashimoto J, Kagaya N, Suenaga H, Ikeda H, Shin-Ya K

Open source

DOI
10.1038/s41598-021-88583-z
Published
2021 May 11
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-021-88583-z,
  title = {Hemiacetal-less rapamycin derivatives designed and produced by genetic engineering of a type I polyketide synthase.},
  author = {Kudo K and Nishimura T and Kozone I and Hashimoto J and Kagaya N and Suenaga H and Ikeda H and Shin-Ya K},
  year = {2021},
  journal = {Scientific reports},
  doi = {10.1038/s41598-021-88583-z},
  url = {https://doi.org/10.1038/s41598-021-88583-z}
}

RIS

TY  - JOUR
TI  - Hemiacetal-less rapamycin derivatives designed and produced by genetic engineering of a type I polyketide synthase.
AU  - Kudo K
AU  - Nishimura T
AU  - Kozone I
AU  - Hashimoto J
AU  - Kagaya N
AU  - Suenaga H
AU  - Ikeda H
AU  - Shin-Ya K
PY  - 2021
JO  - Scientific reports
DO  - 10.1038/s41598-021-88583-z
UR  - https://doi.org/10.1038/s41598-021-88583-z
ER  - 

APA

K, K., T, N., I, K., J, H., N, K., H, S., H, I., & K, S. (2021). Hemiacetal-less rapamycin derivatives designed and produced by genetic engineering of a type I polyketide synthase.. Scientific reports. https://doi.org/10.1038/s41598-021-88583-z

Source records